Maze Therapeutics, Inc.
MAZE- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001842295
In the last 90 days, Maze Therapeutics, Inc. insiders filed 0 open-market purchases and 11 sales; 161 institutions reported holding it in 13F filings for Q2 2026, worth $1.75B in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q1 2026
Institutional positions in Maze Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 165
- +24 vs. Q4 2025
- Shares held
- 51.7M
- +5.01M (+10.7%) vs. Q4 2025
- Total value
- $1.54B
- −$390.0M (−20.2%) vs. Q4 2025
- New holders
- 49
- 58 more added
- Sold out
- 25
- 36 more reduced
2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MAZE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 161 | $1.75B |
| Q1 2026 | 165 | $1.54B |
| Q4 2025 | 143 | $2.00B |
| Q3 2025 | 94 | $1.11B |
| Q2 2025 | 75 | $476.7M |
| Q1 2025 | 68 | $441.4M |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Maze Therapeutics, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nuveen, LLC | 63,360 | $1.89M | 0.00% | +6,102+10.7% | Added |
| Raymond James Financial Inc | 69,375 | $2.07M | 0.00% | +1,657+2.4% | Added |
| Bank of New York Mellon Corp | 74,268 | $2.22M | 0.00% | +13,832+22.9% | Added |
| SummitTX Capital, L.P. | 83,750 | $2.50M | 0.08% | +14,190+20.4% | Added |
| Invesco Ltd. | 86,419 | $2.58M | 0.00% | −47,614−35.5% | Reduced |
| Exome Asset Management LLC | 88,510 | $2.64M | 1.55% | +88,510 | New |
| Alliancebernstein L.P. | 64,762 | $2.68M | 0.00% | +31,542+94.9% | Added |
| UBS Group AG | 93,898 | $2.80M | 0.00% | +65,200+227.2% | Added |
| HighVista Strategies LLC | 99,850 | $2.98M | 0.82% | −70,503−41.4% | Reduced |
| Alyeska Investment Group, L.P. | 100,000 | $2.98M | 0.01% | −96,124−49.0% | Reduced |
| Integral Health Asset Management, LLC | 100,000 | $2.98M | 0.16% | 00.0% | Unchanged |
| Ameriprise Financial Inc | 107,486 | $3.21M | 0.00% | +10,798+11.2% | Added |
| Atika Capital Management LLC | 111,500 | $3.33M | 0.53% | +111,500 | New |
| Price T Rowe Associates Inc | 122,695 | $3.66M | 0.00% | +6,984+6.0% | Added |
| Qube Research & Technologies Ltd | 134,950 | $4.03M | 0.01% | +134,950 | New |
| Holocene Advisors, LP | 136,168 | $4.06M | 0.01% | +136,168 | New |
| Vanguard Fiduciary Trust Co | 151,000 | $4.51M | 0.00% | +151,000 | New |
| Foresite Capital Management IV, LLC | 156,901 | $4.68M | 1.98% | −365,756−70.0% | Reduced |
| Ensign Peak Advisors, Inc | 185,794 | $5.55M | 0.01% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 186,433 | $5.57M | 0.00% | +10,464+5.9% | Added |
| Bank of America Corp | 195,084 | $5.82M | 0.00% | +176,703+961.3% | Added |
| Vanguard Portfolio Management LLC | 195,542 | $5.84M | 0.00% | +195,542 | New |
| Spruce Street Capital LP | 200,000 | $5.97M | 1.44% | +200,000 | New |
| Morgan Stanley | 204,831 | $6.11M | 0.00% | −53,255−20.6% | Reduced |
| Northern Trust Corp | 211,382 | $6.31M | 0.00% | +35,123+19.9% | Added |
| Standard Life Aberdeen plc | 226,227 | $6.75M | 0.01% | +226,227 | New |
| Sphera Funds Management Ltd. | 227,343 | $6.79M | 1.17% | +155,500+216.4% | Added |
| Freestone Grove Partners LP | 234,953 | $7.01M | 0.05% | +116,077+97.6% | Added |
| Mass General Brigham, Inc | 239,994 | $7.16M | 1.53% | 00.0% | Unchanged |
| Squadron Capital Management LLC | 257,500 | $7.69M | 3.08% | −232,500−47.4% | Reduced |
| Candriam Luxembourg S.C.A. | 278,167 | $8.30M | 0.04% | +278,167 | New |
| Goldman Sachs Group Inc | 279,713 | $8.35M | 0.00% | +165,258+144.4% | Added |
| Washington University | 280,802 | $8.38M | 5.23% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 284,476 | $8.49M | 0.20% | −124,896−30.5% | Reduced |
| Marshall Wace, LLP | 310,639 | $9.27M | 0.01% | −536,833−63.3% | Reduced |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 366,028 | $10.9M | 0.65% | −91,507−20.0% | Reduced |
| Farallon Capital Management, L.L.C. | 373,000 | $11.1M | 0.07% | +373,000 | New |
| Ikarian Capital, LLC | 378,999 | $11.3M | 1.62% | −265,681−41.2% | Reduced |
| Balyasny Asset Management LLC | 461,151 | $13.8M | 0.03% | +261,939+131.5% | Added |
| Bessemer Group Inc | 481,790 | $14.4M | 0.02% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 599,967 | $17.9M | 0.00% | +72,686+13.8% | Added |
| Caligan Partners LP | 614,962 | $18.4M | 1.30% | +64,771+11.8% | Added |
| Driehaus Capital Management LLC | 636,162 | $19.0M | 0.14% | +258,147+68.3% | Added |
| State Street Corp | 636,722 | $19.0M | 0.00% | +103,717+19.5% | Added |
| Woodline Partners LP | 650,229 | $19.4M | 0.07% | −385,000−37.2% | Reduced |
| Cormorant Asset Management, LP | 750,000 | $22.4M | 1.13% | +750,000 | New |
| Casdin Capital, LLC | 758,857 | $22.7M | 1.72% | 00.0% | Unchanged |
| ArrowMark Colorado Holdings LLC | 767,383 | $22.9M | 0.61% | 00.0% | Unchanged |
| Citadel Advisors LLC | 775,714 | $23.2M | 0.02% | +327,497+73.1% | Added |
| FMR LLC | 864,214 | $25.8M | 0.00% | +135,609+18.6% | Added |
| TRV GP V, LLC | 950,800 | $28.4M | 7.08% | 00.0% | Unchanged |
| General Catalyst Group Management, LLC | 1,035,910 | $30.9M | 16.85% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 1,178,000 | $35.2M | 0.05% | +1,178,000 | New |
| Logos Global Management LP | 1,235,000 | $36.9M | 1.90% | +285,000+30.0% | Added |
| Alphabet Inc. | 1,388,583 | $41.4M | 1.03% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 1,435,656 | $42.9M | 0.00% | +1,435,656 | New |
| VR Adviser, LLC | 1,602,034 | $47.8M | 1.78% | +53,465+3.5% | Added |
| AH Capital Management, L.L.C. | 1,702,225 | $50.8M | 3.94% | 00.0% | Unchanged |
| BlackRock, Inc. | 2,570,425 | $76.7M | 0.00% | +283,270+12.4% | Added |
| Paradigm Biocapital Advisors LP | 2,744,399 | $81.9M | 1.67% | +2,744,399 | New |
| Janus Henderson Group PLC | 2,858,876 | $85.3M | 0.04% | −283,711−9.0% | Reduced |
| Deep Track Capital, LP | 3,477,562 | $103.8M | 2.14% | −768,878−18.1% | Reduced |
| ARCH Venture Management, LLC | 4,120,053 | $123.0M | 18.16% | 00.0% | Unchanged |
| TRV GP IV, LLC | 4,473,958 | $133.5M | 50.04% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 4,567,274 | $136.3M | 3.51% | 00.0% | Unchanged |
| Bellevue Group AG | 0 | $0 | 0.00% | −887,708−100.0% | Sold out |
| Matrix Capital Management Company, LP | 0 | $0 | 0.00% | −480,000−100.0% | Sold out |
| Eventide Asset Management, LLC | 0 | $0 | 0.00% | −324,041−100.0% | Sold out |
| TCG Crossover Management, LLC | 0 | $0 | 0.00% | −173,816−100.0% | Sold out |
| StemPoint Capital LP | 0 | $0 | 0.00% | −125,877−100.0% | Sold out |
| MPM Oncology Impact Management LP | 0 | $0 | 0.00% | −81,145−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −52,459−100.0% | Sold out |
| Seven Grand Managers, LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −48,200−100.0% | Sold out |
| Cinctive Capital Management LP | 0 | $0 | 0.00% | −29,134−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −24,059−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −14,800−100.0% | Sold out |
| PSP Research LLC | 0 | $0 | 0.00% | −12,672−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −8,493−100.0% | Sold out |
| Landscape Capital Management, L.L.C. | 0 | $0 | 0.00% | −6,050−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −6,047−100.0% | Sold out |
| Profund Advisors LLC | 0 | $0 | 0.00% | −6,016−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −5,668−100.0% | Sold out |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −5,244−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −5,221−100.0% | Sold out |
| WestHill Financial Advisors, Inc. | 0 | $0 | 0.00% | −5,186−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −5,042−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −674−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −160−100.0% | Sold out |
| SageView Advisory Group, LLC | 0 | $0 | 0.00% | −54−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| CIBC Private Wealth Group, LLC | – | – | – | – | Not filed |